小児医療市場：タイプ別、治療薬別、治療タイプ別-2025-2030年の世界予測

小児医療市場の2023年の市場規模は1,060億4,000万米ドルで、2024年には1,136億3,000万米ドルに達すると予測され、CAGR 8.00％で成長し、2030年には1,818億3,000万米ドルに達すると予測されています。

小児医療市場は、医療ケア、ウェルネス、乳幼児、小児、青少年の総合的な健康に焦点を当てた分野と定義され、診断から治療ソリューションまで幅広いサービスを包含しています。この市場は、出生から思春期までの子供の健康を確保する必要性によって推進され、それによって全人的な発達を促進するために急性および慢性疾患を予防・管理します。その用途は、病院、小児科クリニック、薬局、在宅ケアサービスに及び、最終用途は、公的医療機関、民間医療提供者、個人の家庭ケアにまで広がっています。主な成長要因としては、AIを活用した診断などの技術進歩、小児医療問題に対する意識の高まり、ヘルスケア支出の増加などが挙げられます。小児疾患の有病率の増加、人口規模の急増、小児医療機器の革新もこの成長に大きく寄与しています。遠隔医療に投資して遠隔地から小児ヘルスケアにアクセスしたり、個々の遺伝子プロファイルに対応する個別化医療を開発したりすることで、潜在的なビジネスチャンスを活用することができます。制限事項としては、規制上のハードル、研究開発コストの高さ、製品発売を遅らせる可能性のある厳密な臨床試験の必要性などが挙げられます。さらに、市場の断片化や新技術への抵抗といった課題も成長の妨げとなる可能性があります。革新的な分野としては、リアルタイムの健康モニタリングのためのウェアラブル技術の開発や、シームレスなデータ統合のための電子カルテ（EHR）システムの強化などが挙げられます。成長に意欲的な企業は、AIを活用した医療ソリューションの開発や、予測医療モデルのためのビッグデータ分析の活用のために、ハイテク企業とのコラボレーションを模索すべきです。ホリスティックな予防医療、個別化医療の動向を背景に、市場は大きく動いています。現在の複雑な規制に対処し、バイオインフォマティクスを医薬品開発に活用し、異業種とのパートナーシップを促進することで、企業は大きな市場シェアを獲得し、小児ヘルスケアにおける将来の成長を促進することができます。

市場力学：急速に進化する小児医療市場の主要市場インサイトを公開

小児医療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 一般的な小児疾患を患う小児人口の増加
  • 小児予防接種プログラムに対する政府の取り組み
  • 小児慢性疾患の負担増
• 市場抑制要因
  • 新生児や希少な小児疾患を対象とした医薬品の開発が限定的であること
• 市場機会
  • 希少疾患を対象とした新薬や新治療法の研究開発およびイントロダクションの重視
  • 小児用医薬品およびワクチン開発への投資の増加とその利用可能性
• 市場の課題
  • 薬剤に伴う合併症

ポーターの5つの力：小児医療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：小児医療市場における外部からの影響の把握

外部マクロ環境要因は、小児医療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析小児医療市場における競合情勢の把握

小児医療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス小児医療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、小児医療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨小児医療市場における成功への道筋を描く

小児医療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 一般的な小児疾患に苦しむ小児人口の多さ
    • 小児予防接種プログラムに関する政府の取り組み
    • 小児慢性疾患の負担増大
  • 抑制要因
    • 新生児や小児の希少疾患を対象とする医薬品の開発が限定的
  • 機会
    • 希少疾患に対する新薬や新たな治療法の開発の研究開発とイントロダクション注力
    • 小児用医薬品およびワクチンの開発とその供給への投資の増加
  • 課題
    • 薬物に関連する合併症
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 小児医療市場：タイプ別

• 急性疾患
• 慢性疾患

第7章 小児医療市場セラピューティクス

• アレルギーと免疫学
• 心臓病学
• 消化器内科
  • 制酸剤
  • 下痢止め
  • 下剤
• 感染症

第8章 小児医療市場治療の種類別

• 対症療法
  • 薬物
  • ワクチン
• 天然

第9章 南北アメリカの小児医療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の小児医療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの小児医療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Allucent
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• GP Pharm, S.A.
• Henin Lukinz Pvt. Ltd.
• Janssen Global Services LLC
• Medexus Pharmaceuticals, Inc.
• Novartis AG
• ORPHELIA Pharma
• Pfizer Inc.
• Procter & Gamble Company
• Proveca Ltd.
• Sanofi S.A.

LIST OF FIGURES

• FIGURE 1. PEDIATRIC HEALTH MARKET RESEARCH PROCESS
• FIGURE 2. PEDIATRIC HEALTH MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PEDIATRIC HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PEDIATRIC HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PEDIATRIC HEALTH MARKET DYNAMICS
• TABLE 7. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ACUTE ILLNESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CHRONIC ILLNESS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLERGY & IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ANTIDIARRHEAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PEDIATRIC HEALTH MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 43. CANADA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES PEDIATRIC HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 68. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 70. CHINA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 71. CHINA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 73. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 75. INDIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 76. INDIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 159. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 161. ITALY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ITALY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 179. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 181. POLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 182. POLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 184. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 186. QATAR PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 187. QATAR PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY GASTROENTEROLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM PEDIATRIC HEALTH MARKET SIZE, BY ALLOPATHIC, 2018-2030 (USD MILLION)
• TABLE 234. PEDIATRIC HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 235. PEDIATRIC HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

The Pediatric Health Market was valued at USD 106.04 billion in 2023, expected to reach USD 113.63 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 181.83 billion by 2030.

The pediatric health market, defined as the sector focusing on medical care, wellness, and the overall health of infants, children, and adolescents, encompasses a range of services from diagnostics to treatment solutions. This market is driven by the necessity to ensure child health from birth through adolescence, thereby preventing and managing acute and chronic conditions to foster holistic development. Its application spans hospitals, pediatric clinics, pharmacies, and home care services, with end-use extending into public health organizations, private healthcare providers, and individual family care. Key growth factors include technological advancements like AI-driven diagnostics, growing awareness of pediatric health issues, and increased healthcare expenditure. The increasing prevalence of pediatric diseases, the booming population size, and innovation in pediatric medical devices also contribute significantly to this growth. Potential opportunities can be harnessed by investing in telemedicine for remote child healthcare access and developing personalized medicine to cater to individual genetic profiles. Limitations include regulatory hurdles, high R&D costs, and the need for rigorous clinical trials which can delay product launches. Additionally, challenging factors such as market fragmentation and resistance to new technologies could hinder growth potential. Innovation areas include development in wearable technology for real-time health monitoring and enhancing electronic health record (EHR) systems for seamless data integration. Businesses keen on growth should explore collaborations with tech firms to create AI-powered medical solutions and leverage big data analysis for predictive health care models. The market is profoundly dynamic, with a trend towards holistic, preventive, and personalized care. By addressing current regulatory complexities, utilizing bioinformatics for drug development, and fostering cross-industry partnerships, firms can capture significant market share and drive future growth in pediatric healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Health Market

The Pediatric Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Significant pediatric population suffering from common childhood Illnesses
  • Government initiatives for pediatric immunization programs
  • Rising burden of chronic pediatric diseases
• Market Restraints
  • Limited development of drugs targeting neonates and rare pediatric diseases
• Market Opportunities
  • Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
  • Increasing investment in pediatric drug & vaccine development and its availability
• Market Challenges
  • Complications associated with drugs

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Health Market

A detailed market share analysis in the Pediatric Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Health Market

A strategic analysis of the Pediatric Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Health Market, highlighting leading vendors and their innovative profiles. These include Allucent, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Gilead Sciences, Inc., GlaxoSmithKline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Janssen Global Services LLC, Medexus Pharmaceuticals, Inc., Novartis AG, ORPHELIA Pharma, Pfizer Inc., Procter & Gamble Company, Proveca Ltd., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Pediatric Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Acute Illness and Chronic Illness.
• Based on Therapeutics, market is studied across Allergy & Immunology, Cardiology, Gastroenterology, and Infectious Disease. The Gastroenterology is further studied across Antacids, Antidiarrheal, and Laxatives.
• Based on Treatment Type, market is studied across Allopathic and Natural. The Allopathic is further studied across Drugs and Vaccines.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Significant pediatric population suffering from common childhood Illnesses
    • 5.1.1.2. Government initiatives for pediatric immunization programs
    • 5.1.1.3. Rising burden of chronic pediatric diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Limited development of drugs targeting neonates and rare pediatric diseases
  • 5.1.3. Opportunities
    • 5.1.3.1. Focus on R&D and introduction of novel drugs and new therapeutic developments on rare diseases
    • 5.1.3.2. Increasing investment in pediatric drug & vaccine development and its availability
  • 5.1.4. Challenges
    • 5.1.4.1. Complications associated with drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pediatric Health Market, by Type

• 6.1. Introduction
• 6.2. Acute Illness
• 6.3. Chronic Illness

7. Pediatric Health Market, by Therapeutics

• 7.1. Introduction
• 7.2. Allergy & Immunology
• 7.3. Cardiology
• 7.4. Gastroenterology
  • 7.4.1. Antacids
  • 7.4.2. Antidiarrheal
  • 7.4.3. Laxatives
• 7.5. Infectious Disease

8. Pediatric Health Market, by Treatment Type

• 8.1. Introduction
• 8.2. Allopathic
  • 8.2.1. Drugs
  • 8.2.2. Vaccines
• 8.3. Natural

9. Americas Pediatric Health Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pediatric Health Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pediatric Health Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Allucent
• 2. AstraZeneca PLC
• 3. Boehringer Ingelheim International GmbH
• 4. Gilead Sciences, Inc.
• 5. GlaxoSmithKline PLC
• 6. GP Pharm, S.A.
• 7. Henin Lukinz Pvt. Ltd.
• 8. Janssen Global Services LLC
• 9. Medexus Pharmaceuticals, Inc.
• 10. Novartis AG
• 11. ORPHELIA Pharma
• 12. Pfizer Inc.
• 13. Procter & Gamble Company
• 14. Proveca Ltd.
• 15. Sanofi S.A.